|
This report is being submitted to report additional information.The following sections are being reported: d4: expiration date is not provided / unknown.D4: unique identifier (udi) number h2: if follow-up, what type h3: device evaluated by manufacturer h4: device manufacturer date h6: health effect - clinical code h6: device code(s) h6: type of investigation h6: investigation findings h6: investigation conclusions h10: additional narratives/data the product was returned and the reported event (fracture) was confirmed following inspection and evaluation of the returned product.Based on the evaluation, the device malfunction did occur.However, there is no existing nonconformance/capa/hhe/d/ie/product holds against the reported devices that could cause or contribute to the reported event.Monthly post market trending review identified no adverse trends or corrective actions for the reported event or device.Zimvie quality management system (qms) has controls in place to ensure the distribution of conforming product.Therefore, based on the available information, the products were likely within specifications and conforming when they left zimmer biomet.Dhr review was completed for the subject lot number (8696220-1).It was confirmed that all operations and inspections were executed as per applicable procedure.No deviations or non-conformances, which could have caused or contributed to the reported event was noted as part of the dhr.Lot was inspected and passed all acceptance criteria by qa.A definitive root cause could not be determined.No further investigation or immediate capa/hhe/d escalation is required, as the complaint investigation could not confirm the product was nonconforming at the time of distribution, and no new failure mode, harm, or hazardous situation was identified through the investigation performed.If any further information is found which would change or alter any conclusions or information, a supplemental report will be filed accordingly.Zimvie will continue to monitor for trends.
|